Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean calcium bromide?
Displaying drugs 326 - 329 of 329 in total
Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.
Investigational
Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks. Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential...
Investigational
Displaying drugs 326 - 329 of 329 in total